| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.017 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |